drjessemorse
Substacknewsletter · by drjessemorse
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Several times a week
- From 10 posts indexed in the last 90 days
- Last post
- Nov 10, 2026
- 2 days ago
- Likely audience
- Endocrinologists
- Inferred from post content
drjessemorse is a Substack newsletter by drjessemorse covering Type 2 Diabetes Treatment, Retatrutide and GLP-1 Agonists. NewsletterFIT indexed 10 posts from it in the last 90 days, most recently on Nov 10, 2026.
Topics
- Type 2 Diabetes Treatment
- Retatrutide
- GLP-1 Agonists
- Clinical Trial Results
- Weight Loss Drugs
Recent posts
- GLP-1s Aren’t…
- Stem Cells…
- The First…
- A Longevity…
- The Next…
- Doctors Want…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on drjessemorse
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
drjessemorse alternatives: similar newsletters
Ranked by how many topics they share with drjessemorse.
- Dr. Michael Okun on Parkinson's & Brain Health11K subscribers
SubstackMonthly or less · last post 31 days ago
Likely audience: Patients with Parkinson's disease
1 shared topic
- Michael Halassa2K subscribers
SubstackEvery two weeks · last post 21 days ago
Likely audience: cognitive scientists
1 shared topic
- GLP-1 Digest 2K subscribers
SubstackMonthly or less · last post 34 days ago
Likely audience: Healthcare investors
1 shared topic
SubstackWeekly · last post 6 days ago
Likely audience: Healthcare professionals
1 shared topic
LinkedInEvery two weeks · last post 20 days ago
Likely audience: Healthcare investors
1 shared topic
LinkedInWeekly · last post 14 days ago
Likely audience: Pharmaceutical executives
1 shared topic
Compiled from public pages · refreshed Nov 10, 2026 · How NewsletterFIT collects and labels data